Company news
Jiangsu Kanion Pharmaceutical Co. Ltd. news in 2026
Jiangsu Kanion Pharmaceutical Co. Ltd.'s news releases, calls and decks from 2026, newest first.
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Reimbursement Drug List
November 15, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
November 2, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Report for Q3 2026
October 29, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Key Operating Data for the First Three Quarters of 2026
October 29, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Receipt of the Clinical Trial Approval Notice for Shiwei Anchang Granules
October 22, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Departure of Senior Executive
October 16, 2026
(600557)"Jiangsu Kanion Pharmaceutical Co., Ltd."Announcement on Progress in Repurchasing Shares through Call Auction
October 9, 2026
Semi-annual Report for 2026
August 27, 2026
Announcement on Receipt of the Clinical Trial Approval Notice for Qihuang Zhengqi Granules
July 21, 2026
Announcement on Initially Repurchasing Shares through Call Auction
July 16, 2026
Announcement on Inclusion of Certain Pharmaceutical Products of the Company in the National Essential Medicines List
July 9, 2026
Announcement on Progress in Repurchasing Shares through Call Auction
July 3, 2026
Announcement on Cancellation of Repurchased Shares and Notification to Creditors
June 26, 2026
Announcement on Shareholding of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Limit
June 22, 2026
Notice on Convening the 2025 Annual General Meeting
June 5, 2026
Report for Q1 2026
April 29, 2026
Announcement on Convening Performance Briefing for 2025 and Q1 2026
April 28, 2026
Announcement on Renewing Engagement of Accounting Firm
April 22, 2026
Announcement on Receiving the Clinical Trial Approval Notice for Qingshen Tongluo Granules
April 19, 2026
Announcement on Appointment of Deputy General Manager
March 30, 2026
Announcement on Receiving the Clinical Trial Approval Notice for Heihuang Chizhu Granules
February 25, 2026
Announcement on the Receipt of the Clinical Trial Approval Notice for Yunpi Huatan Tongqiao Granules
January 26, 2026
Announcement on the Receipt of the Clinical Trial Approval Notice for Plantago Seed Tablets
January 20, 2026